startups technology enabled weight loss services glp-1 Matthew Gallagher founded Medvi, a telehealth platform for GLP-1 Agonists Market Report 2025-2033,

Im not worried, Im terrified, says 71-year-old Ann Rezarch, who takes compounded tirzepatide for lipedema and says she cannot afford the name-brand meds

Its straightforward structure allows studies to focus on biological effects with minimal setup

Coverage requires provider approval, prior authorization, and CMS eligibility rules

New research from Blue Cross Blue Shield reveals that, among 170,000 patients using a GLP-1 for weight management, 58% discontinued use before reaching a clinically meaningful health benefit

Dual agonism of GIP and GLP-1 produced superior glycemic control and body weight reduction compared to GLP-1 receptor agonism alone (Frias, New England Journal of Medicine )